AnaptysBio (ANAB) reported Q2 net income late Monday of $5.11 per diluted share, swinging from the loss of $1.30 a year earlier.
Revenue in the three months ended June 30 rose to $27.5 million from $22.3 million a year earlier.
The company's shares rose 4.5% in after-hours trading.